Literature DB >> 8975699

Identification of new members of the Gas2 and Ras families in the 22q12 chromosome region.

J Zucman-Rossi1, P Legoix, G Thomas.   

Abstract

Monitoring of loss of heterozygosity in human tumors has suggested that the 22q12 region may contain another tumor suppressor gene(s) in addition to the NF2 gene. The genomic sequencing of a 40-kb region bounded by the EWS and BAM22 genes and containing a CpG-rich region has identified two new genes in the q12 region of chromosome 22. One of them, GAR22, is closely related to mouse Gas2, a gene isolated as being negatively regulated by serum and growth factors and exhibiting a high expression in growth arrested mouse fibroblasts. The other, RRP22, belongs to the Ras superfamily, in which it defines a new subgroup. Its expression appears to be strictly limited to the central nervous system. Growth-arrest-specific and Ras-related genes are likely candidates to be involved in tumorigenic processes. Although no mutation was observed in a small set of meningiomas and schwannomas, alteration of these new genes should now be searched in other tumors with frequent allelic losses on chromosome 22 not associated with NF2 mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8975699     DOI: 10.1006/geno.1996.0625

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Deletion of Gas2l3 in mice leads to specific defects in cardiomyocyte cytokinesis during development.

Authors:  Sabine Stopp; Marco Gründl; Marc Fackler; Jonas Malkmus; Marina Leone; Ronald Naumann; Stefan Frantz; Elmar Wolf; Björn von Eyss; Felix B Engel; Stefan Gaubatz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-11       Impact factor: 11.205

2.  RRP22: a novel neural tumor suppressor for astrocytoma.

Authors:  Ruokun Chen; Liang Yang; Jiasheng Fang; Lei Huo; Mingyu Zhang; Fenghua Chen; Jinfang Liu; Jun Wu; Yanjin Wang
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

3.  Chromosome translocation based on illegitimate recombination in human tumors.

Authors:  J Zucman-Rossi; P Legoix; J M Victor; B Lopez; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

4.  Characterization of G2L3 (GAS2-like 3), a new microtubule- and actin-binding protein related to spectraplakins.

Authors:  Matthew J Stroud; Richard A Kammerer; Christoph Ballestrem
Journal:  J Biol Chem       Date:  2011-05-11       Impact factor: 5.157

Review 5.  Gene expression profiling of meningiomas: current status after a decade of microarray-based transcriptomic studies.

Authors:  Mads Aarhus; Morten Lund-Johansen; Per Morten Knappskog
Journal:  Acta Neurochir (Wien)       Date:  2011-01-14       Impact factor: 2.216

6.  Microtubule actin cross-linking factor (MACF): a hybrid of dystonin and dystrophin that can interact with the actin and microtubule cytoskeletons.

Authors:  C L Leung; D Sun; M Zheng; D R Knowles; R K Liem
Journal:  J Cell Biol       Date:  1999-12-13       Impact factor: 10.539

7.  DNA methylation, histone modifications, and signal transduction pathways: a close relationship in malignant gliomas pathophysiology.

Authors:  Raúl Alelú-Paz; Nadia Ashour; Ana González-Corpas; Santiago Ropero
Journal:  J Signal Transduct       Date:  2012-07-17

8.  Kakapo, a novel cytoskeletal-associated protein is essential for the restricted localization of the neuregulin-like factor, vein, at the muscle-tendon junction site.

Authors:  D Strumpf; T Volk
Journal:  J Cell Biol       Date:  1998-11-30       Impact factor: 10.539

9.  Regulation of atrial natriuretic peptide secretion by a novel Ras-like protein.

Authors:  Igor I Rybkin; Mi-Sung Kim; Svetlana Bezprozvannaya; Xiaoxia Qi; James A Richardson; Craig F Plato; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Cell Biol       Date:  2007-11-05       Impact factor: 10.539

10.  Progress in the molecular biology of ewing tumors.

Authors:  H Kovar
Journal:  Sarcoma       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.